Spero Therapeutics, Inc.·4

Oct 10, 5:18 PM ET

Mahadevia Ankit 4

4 · Spero Therapeutics, Inc. · Filed Oct 10, 2023

Insider Transaction Report

Form 4
Period: 2023-10-05
Transactions
  • Award

    Common Stock

    2023-10-05+20,000808,792 total
Footnotes (2)
  • [F1]Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest on October 5, 2024, subject to the Reporting Person's continued service through the applicable vesting date.
  • [F2]Amount includes 65,817 shares of common stock held by the Mahadevia-Mehta Family Trust, of which the Reporting Person is a trustee.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4